Masimo Corporation (MASI)
Automate Your Wheel Strategy on MASI
With Tiblio's Option Bot, you can configure your own wheel strategy including MASI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MASI
- Rev/Share 36.5481
- Book/Share 17.5259
- PB 9.434
- Debt/Equity 0.7201
- CurrentRatio 2.1665
- ROIC -0.1329
- MktCap 8964585994.0
- FreeCF/Share 2.6907
- PFCF 61.6971
- PE -18.0553
- Debt/Assets 0.2972
- DivYield 0
- ROE -0.4095
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Reiterated | MASI | Raymond James | -- | Outperform | $170 | $194 | Dec. 27, 2024 |
News
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
Published: June 04, 2025 by: Business Wire
Sentiment: Neutral
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders. What can I do? If you are a current Masimo Corporation shareholder, you may have legal claims that may be brought on behalf of the company, against the company's directors and officers. If you wish to discuss this.
Read More
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
Published: May 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to their obligations to the company's shareholders.
Read More
Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
Read More
MASI Stock Slips Despite Q1 Earnings and Revenue Beat, Margins Expand
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
Masimo's first-quarter 2025 results continue to benefit from the strength in its Healthcare businesses despite tariff-related uncertainties.
Read More
Masimo to Present in the BofA Securities 2025 Health Care Conference
Published: May 07, 2025 by: Business Wire
Sentiment: Neutral
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025 at 4:20 p.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of in.
Read More
Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Masimo Corporation (NASDAQ:MASI ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Katie Szyman - Chief Executive Officer Micah Young - Executive Vice President, Chief Financial Officer Eli Kammerman - Vice President of Business Development, Investor Relations Conference Call Participants Frederick Wise - Stifel Financial Vik Chopra - Wells Fargo Jason Bednar - Piper Sandler Mike Matson - Needham Matt Taylor - Jeffries Michael Polark - Wolfe Operator Good afternoon, ladies and gentlemen. And welcome to Masimo's First Quarter 2025 Earnings Conference Call.
Read More
Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) came out with quarterly earnings of $1.36 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $0.77 per share a year ago.
Read More
Samsung Electronics says unit Harman acquires Masimo's audio business for $350 mln
Published: May 06, 2025 by: Reuters
Sentiment: Positive
Samsung Electronics said on Wednesday its unit Harman International signed a deal to acquire U.S. firm Masimo's audio business for $350 million.
Read More
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Positive
MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.
Read More
Why Masimo (MASI) Could Beat Earnings Estimates Again
Published: April 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Why You Shouldn't Bet Against Masimo (MASI) Stock
Published: April 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Read More
Here's Why Masimo (MASI) is a Strong Growth Stock
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes
Published: April 02, 2025 by: Zacks Investment Research
Sentiment: Neutral
In 2025, companies like MASI, BSX and HIMS are expected to overcome challenges and sustain strong growth and market leadership.
Read More
Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why
Published: April 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
3 Reasons Growth Investors Will Love Masimo (MASI)
Published: March 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
Read More
Buy 3 Momentum Anomaly Stocks as Tariffs Take a Toll on Markets
Published: March 13, 2025 by: Zacks Investment Research
Sentiment: Neutral
MASI, HOOD and DFS are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Read More
Here's Why Masimo (MASI) is a Strong Momentum Stock
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Here is Why Growth Investors Should Buy Masimo (MASI) Now
Published: February 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) possesses solid growth attributes, which could help it handily outperform the market.
Read More
Masimo (MASI) Upgraded to Strong Buy: What Does It Mean for the Stock?
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Positive
FMS, MASI and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar the prospects.
Read More
Masimo (MASI) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Masimo (MASI) Tops Q4 Earnings and Revenue Estimates
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Masimo (MASI) came out with quarterly earnings of $1.80 per share, beating the Zacks Consensus Estimate of $1.49 per share. This compares to earnings of $1.25 per share a year ago.
Read More
Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript
Published: February 25, 2025 by: Seeking Alpha
Sentiment: Neutral
Masimo Corporation (NASDAQ:MASI ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Eli Kammerman - Vice President, Business Development & Investor Relations Katie Szyman - Chief Executive Officer Micah Young - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Jason Bednar - Piper Sandler Rick Wise - Stifel Michael Polark - Wolfe Research Vik Chopra - Wells Fargo Mike Matson - Needham Operator Good afternoon, ladies and gentlemen, and welcome to Masimo's Fourth Quarter and Full Year 2024 Earnings Conference Call. The company's press release is available at www.masimo.com.
Read More
Masimo Tops EPS, Revenue Expectations
Published: February 25, 2025 by: The Motley Fool
Sentiment: Positive
Masimo (MASI -0.69%), a provider of noninvasive patient monitoring technology, released its fourth-quarter earnings for 2024, on Feb. 25, 2025. The results presented a mixed picture: strong performance was seen in its core healthcare segment, with revenue reaching $601 million, surpassing analyst expectations of $592 million.
Read More
About Masimo Corporation (MASI)
- IPO Date 2007-08-08
- Website https://www.masimo.com
- Industry Medical - Instruments & Supplies
- CEO Ms. Catherine M. Szyman
- Employees 3600